Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022

View ORCID ProfileElisabetta Colosi, View ORCID ProfileGiulia Bassignana, View ORCID ProfileAlain Barrat, View ORCID ProfileBruno Lina, View ORCID ProfilePhilippe Vanhems, View ORCID ProfileJulia Bielicki, View ORCID ProfileVittoria Colizza
doi: https://doi.org/10.1101/2022.02.04.22270473
Elisabetta Colosi
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elisabetta Colosi
Giulia Bassignana
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giulia Bassignana
Alain Barrat
2Aix Marseille Univ, Université de Toulon, CNRS, CPT, Turing Center for Living Systems, Marseille, France
3Tokyo Tech World Research Hub Initiative (WRHI), Tokyo Institute of Technology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alain Barrat
Bruno Lina
4National Reference Center for Respiratory Viruses, Department of Virology, Infective Agents Institute, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France
5Virpath Laboratory, International Center of Research in Infectiology, INSERM U1111, CNRS—UMR 5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon, Lyon University, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruno Lina
Philippe Vanhems
6Service d’Hygiène, Épidémiologie, Infectiovigilance et Prévention, Hospices Civils de Lyon, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philippe Vanhems
Julia Bielicki
7Paediatric Infectious Diseases, University of Basel Children’s Hospital, Spitalstrasse 33, 4056, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Julia Bielicki
Vittoria Colizza
1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
3Tokyo Tech World Research Hub Initiative (WRHI), Tokyo Institute of Technology, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vittoria Colizza
  • For correspondence: vittoria.colizza{at}inserm.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

As record cases due to the Omicron variant are currently registered in Europe, schools remain a vulnerable setting suffering large disruption. Extending previous modeling of SARS-CoV-2 transmission in schools in France, we estimate that at high incidence rates reactive screening protocols (as currently applied in France) require comparable test resources as weekly screening (as currently applied in some Swiss cantons), for considerably lower control. Our findings can be used to define incidence levels triggering school protocols and optimizing their cost-effectiveness.

Countries in Europe are currently suffering disruptions in schools due to the exceptionally high rates of Omicron incidence in the community and in particular in children1. School protocols are put under stress by requiring repeated quarantines or leading to large and sudden testing demand for children, overloading saturated surveillance systems2,3. Through modelling, here we compare school protocols in terms of resource peak demands, infection prevention, and reduction of schooldays lost, specifically under the high incidence conditions due to the Omicron variant.

Modelling SARS-CoV transmission in schools and school protocols

We extended a stochastic agent-based model of SARS-CoV-2 transmission at school presented in detail by Colosi et al.4 (see Supplementary Information, SI). Infection progression includes prodromic, clinical and subclinical disease stages, informed from empirical distributions, and accounted for children’s lower susceptibility and transmissibility5,6.

Next to symptomatic testing, we simulated the reactive protocol currently applied in France, requesting an anterior nasal LFD test at days D0, D2, and D4 to the class of the detected case7. We compared it to two regular screening strategies, with weekly (as in the Baselland canton, Switzerland8) and semiweekly frequencies, assuming 75% (50-100%) adherence. Finally, we considered the reactive class quarantine after case detection, currently applied in Italian pre-primary schools9. Case isolation lasted 7 days.

The model was informed with time-varying and age-dependent test sensitivity, yielding estimated 67% peak sensitivity for asymptomatic children in nasal LFD tests and 96% in salivary PCR tests10 (SI). We also explored a lower peak sensitivity of 55%.

Omicron epidemiological scenarios and test needs

We considered the circulation of the Omicron variant, assuming 20% protection from infection from prior variants11, an intrinsic transmissibility advantage of 30%-80% relative to Delta12, and a shorter incubation period12,13. The advantage is applied to the within-school transmissibility of previously circulating variants that we inferred in prior work from observed prevalence in French schools4 (SI).

Following current vaccine coverage in France, we considered that all teachers completed the primary vaccination (with estimated vaccine effectiveness against symptomatic disease from Omicron infection VE=50% at 3 months after the second dose14), with 50% of them having received the booster (VE=70% within the first 4 weeks14). In a first analysis, we assumed no vaccinated children (French coverage <3% by mid-January15).

The simulated Omicron wave captures the dynamics reported by community surveillance incidence in primary school students15 (Figure 1A). The reactive protocol marginally reduces the peak, whereas regular screening flattens more substantially the curve. The number of tests required by the reactive protocol increases along the wave, with a predicted peak demand of 0.45 (95% bootstrap CI 0.44-0.48) tests per student per week at an incidence close to 7,000 cases per 100,000 (Figure 1C). Test demand instead decreases in the regular protocols because fewer students are present in class after the peak of infections due to isolation (0.457 (0.457-0.461) tests in the weekly and 0.97 (0.97-0.98) in the semiweekly screening). Higher incidence conditions can lead to a larger demand of tests by the reactive protocol compared to the weekly screening (Figure 1BD).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Incidence and number of tests per student over time under different school protocols.

A,B: simulated weekly incidence expressed in number of cases in students per 100,000 over time for lower (A) and higher (B) introduction conditions, for different protocols. The left plot also shows the reported incidence in the 6-10y age class in France in the period 02-18/01/202215. C,D: average number of tests per student over time for reactive and regular protocols under the epidemic conditions illustrated in the top panels. The horizontal dashed lines indicate the theoretical values of the demands in number of tests per student in the weekly and semiweekly screening (i.e. imposed by 75% adherence and by the frequency). Results are obtained considering the use of nasal LFD tests in both reactive and regular screenings. Shaded areas around the curves correspond to 95% bootstrap confidence intervals.

Resource needs vs. impact on cases and schooldays lost

To evaluate how to best use resources, we extended the analysis of Figure 1 to a larger set of Omicron wave scenarios with varying peak incidence (SI). For increasing values of the incidence rate, from approximately 4,000 to 10,000 cases per 100,000, the number of reactive tests per student-week increases from 0.25 to 0.61 (Figure 2A). However, these tests would have marginal control of the viral circulation at school, reducing the peak of the wave by <10% (Figure 2B). For incidence up to 7,100 cases per 100,000 in absence of interventions, weekly screening would lower the peak by >20% while requiring <0.46 tests per student-week at peak (Figure 2AB). The same impact could be achieved even for higher incidence rates (<10,100 cases per 100,000) by doubling the frequency. Similar results are obtained considering the reduction of the epidemic size of the full wave (SI).

Figure 2.
  • Download figure
  • Open in new tab
Figure 2. Test needs and schooldays lost vs. peak reduction at varying peak incidence rates.

A: Demand in the number of tests per student-week at peak as a function of the peak incidence (cases in students per 100,000) for the reactive, weekly, and semiweekly protocols. The horizontal dashed lines indicate the theoretical values of the number of tests per student in the weekly and semiweekly screening (i.e. imposed by 75% adherence and the frequency). Dots reduce their transparency for increasing incidence. B: Demand in the number of tests per student-week at peak as a function of the percentage of peak reduction achieved by each protocol compared to symptomatic testing (i.e. in absence of interventions). The horizontal dashed lines are as in panel A. Dots transparency code is the same as in panel A. C: Peak percentage of student-days lost as a function of the percentage of peak reduction achieved by each protocol; both quantities are computed with respect to symptomatic testing. The reactive quarantine of the class is shown as an additional protocol. In panels B and C: incidence values in the legend refer to peak incidence of symptomatic testing (i.e. in absence of interventions); the corresponding values for each protocol are plotted in panel A; arrows are shown as guide to the eye.

Student-days lost remain below 11% with reactive and weekly screening, whereas reactively closing the class could lead to >20% of absence per student, compatible with observations3 (Figure 2C). Findings are robust against changes in booster coverage in teachers, in Omicron transmissibility and incubation period (SI). Higher detection rates would penalize the reactive screening, due to an increase in test demand while control remains limited (SI).

Impact of test type, adherence, vaccination of children

Changing from nasal LFD tests to salivary PCR tests would improve the reactive strategy from 9% to 14% peak reduction if results are available after 12h (Figure 3A). Regular testing is instead mainly affected by adherence (Figure 3B). Vaccinating children would provide a collective benefit in reducing viral circulation at school. Assuming the vaccine effectiveness estimate for adults after 2 Pfizer doses (VE=60%)14, the peak would be reduced by 30%-45% for 40% to 60% coverage with the reactive screening, and by 35%-50% with weekly screening, compared to no vaccination (Figure 3C). For VE=20%, accounting for waning14, the reductions would be in the range 19-28% and 22-33% with the reactive and weekly screening, respectively.

Figure 3.
  • Download figure
  • Open in new tab
Figure 3. Impact of test sensitivity, adherence to regular screening, and vaccination.

A: Percentage of peak reduction achieved by each protocol compared to symptomatic testing (i.e. in absence of interventions) as a function of the test sensitivity10 and of the delay in returning the results (+12h, +24h for PCR tests). The lower value corresponds to 55% peak sensitivity. B: Percentage of peak reduction as a function of adherence to regular screening. C: Reduction (%) in the peak incidence for each protocol due to vaccination in children, for different vaccination coverages. Vaccine effectiveness against symptomatic disease is set to VE=60% (solid bars), assuming the estimate of two Pfizer vaccine doses against Omicron obtained in adults14, and VE=20% (transparent bars), corresponding to the waned effectiveness estimated 3-4 months after the second dose14. Results of all panels refer to the Omicron wave shown in Figure 1A.

Discussion

Given the high incidence rates currently recorded in Europe due to the Omicron variant1, our study shows that reactive screening strategies in schools, as employed in France, would require a similar number of tests per student per week compared to weekly screening, but achieve a lower epidemic control. The protocol requesting three tests in less than a week for case contacts in French primary schools led to large disruption in January 2022, in terms of logistics, resources, and impact on surveillance capacity2. We estimate that the same resources would be more efficiently used by weekly screening schools, reaching 20-40% peak reduction for incidence rates up to the values currently registered in France15, compared to the marginal reduction (<10%) of reactive screening.

Other countries opted for systematically screening schools against SARS-CoV-2 transmission, supported by numerical evidence4,16–19. Authorities in Baselland (Switzerland) offered weekly salivary PCR tests to all schools since March 2021. Prior to making participation mandatory in 2022, recorded adherence was on average >75%8. Proactively screening also has the advantage of planning resources in advance, contrary to reactive screening subject to sudden peak demands and potential shortages. This was reported to help simplifying the logistics of test-to-stay strategies in pilot weekly screenings implemented in a number of pre-primary and primary schools in the Auvergne-Rhône-Alpes region in France. Preliminary unpublished empirical estimates from these screenings also suggest a reduction of cases in December 2021 compared to the reactive strategy, in line with model predictions.

The now widespread use of nasal antigenic tests makes repeated self-testing possible without loss in efficiency, as lower sensitivity is compensated by promptness of results and high frequency. It would also limit the high rates of absence from school due to reactive class closures that are predicted by the model and currently reported3.

As European countries approach the peak of the Omicron wave, these findings can be used to tune the response by defining incidence levels triggering protocols adapting to the decreasing phase of the wave, according to the established objectives. Systematically screening schools remains the optimal test-to-stay strategy, reducing peak incidence rates in children, and thus their consequences on hospitalizations and long COVID20, while limiting school disruption and resources. Large vaccination coverage in children contributes to mitigate high viral circulation, making schools safer. Current coverage remains however low in children in several European countries (14% median coverage for first dose vaccination by week 4 2022; SI).

Our study has limitations. We did not fit the model to the Omicron wave in a specific country, as we aimed to evaluate protocols’ resources and impact in a range of high incidence conditions experienced across countries in Europe. Nonetheless, the model follows the observed dynamics in France. With remaining uncertainty on Omicron features, we assumed that its higher spreading rate was mainly due to immune evasion12, in line with observations from household studies21. Considering a higher intrinsic transmission led to similar conclusions. We did not consider immunity waning over time, but tested waned vaccine effectiveness.

A large demand in tests results from reactively screening schools in high incidence conditions. Comparable resources could be more efficiently used in a proactive screening strategy to mitigate the peak.

Data Availability

All data produced in the present work are contained in the manuscript

Acknowledgments

We thank Thomas Bénet for useful discussions. This study was partially funded by: ANR projects COSCREEN (ANR-21-CO16-0005) and DATAREDUX (ANR-19-CE46-0008-03); ANRS-MIE project EMERGEN (ANRS0151); EU H2020 grants MOOD (H2020-874850) and RECOVER (H2020-101003589); EU HORIZON grant VERDI (101045989); REACTing COVID-19 grant.

References

  1. 1.↵
    ECDC. Country overview report: week 3 2022. European Centre for Disease Prevention and Control https://www.ecdc.europa.eu/en/covid-19/country-overviews (2022).
  2. 2.↵
    Morin, V. et al. Covid-19 : dans les écoles, la semaine de toutes les tensions. Le Monde (2022).
  3. 3.↵
    Fregonara, G. Più che raddoppiate le classi in Dad. Medie e superiori, si torna senza tampone. Corriere della Sera https://www.corriere.it/scuola/secondaria/22_gennaio_28/raddoppiano-classi-dad-20-cento-studenti-casa-81a371d0-802f-11ec-9fac-a85f17701932.shtml (2022).
  4. 4.↵
    Colosi, E. et al. Screening and vaccination against COVID-19 to minimize school closure. medRxiv preprint 2021.08.15.21261243 (2021) doi:10.1101/2021.08.15.21261243.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Viner, R. M. et al. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. JAMA Pediatrics 175, 143 (2021).
    OpenUrl
  6. 6.↵
    Dattner, I. et al. The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children. PLOS Computational Biology 17, (2021).
  7. 7.↵
    Ministère de l’Education Nationale de la Jeunesse et des Sports. Année scolaire 2021-2022 : protocole sanitaire et mesures de fonctionnement. Ministère de l’Education Nationale de la Jeunesse et des Sports https://www.education.gouv.fr/annee-scolaire-2021-2022-protocole-sanitaire-et-mesures-de-fonctionnement-324257.
  8. 8.↵
    Basel Landschaft. Covid-19 Breites Testen BL. baselland.ch https://www.baselland.ch/politik-und-behorden/direktionen/volkswirtschafts-und-gesundheitsdirektion/amt-fur-gesundheit/medizinische-dienste/kantonsarztlicher-dienst/aktuelles/covid-19-faelle-kanton-basel-landschaft/covid-19-breites-testen-bl.
  9. 9.↵
    MIUR. Nota tecnica -Indicazioni per l’individuazione e la gestione dei contatti di casi di infezione da SARS-CoV-2 in ambito scolastico. Ministero dell’Istruzione Ministero dell’Università e della Ricerca https://www.miur.gov.it/documents/20182/0/Nota+tecnica+-+Indicazioni+per+l%E2%80%99individuazione+e+la+gestione+dei+contatti+di+casi+di+infezione+da+SARS-CoV-2+in+ambito+scolastico.pdf/838ef7ff-225c-2cbe-f3b8-a90448e10fc9?version=1.0&t=1636204411355 (2021).
  10. 10.↵
    Smith, R. L. et al. Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection. The Journal of Infectious Diseases 224, 976–982 (2021).
    OpenUrl
  11. 11.↵
    Ferguson, N. et al. Report 49: Growth, population distribution and immune escape of Omicron in England. http://spiral.imperial.ac.uk/handle/10044/1/93038 (2021) doi:10.25561/93038.
    OpenUrlCrossRef
  12. 12.↵
    Faes, C. et al. SARS-CoV-2 variants and vaccination in Belgium. https://covid-en-wetenschap.github.io/assets/20220105_technical_note_SIMID.pdf (2022).
  13. 13.↵
    Jansen, L. et al. Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021. MMWR Morb Mortal Wkly Rep 70, (2021).
  14. 14.↵
    UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing: Update on hospitalisation and vaccine effectiveness for Omicron VOC-21NOV-01 (B.1.1.529). 17 (2021).
  15. 15.↵
    Géodes - Santé publique France - Indicateurs : cartes, données et graphiques. https://geodes.santepubliquefrance.fr/#view=map2&c=indicator.
  16. 16.↵
    Leng, T. et al. Quantifying within-school SARS-CoV-2 transmission and the impact of lateral flow testing in secondary schools in England. medRxiv preprint 2021.07.09.21260271 (2021) doi:10.1101/2021.07.09.21260271.
    OpenUrlAbstract/FREE Full Text
  17. 17.
    McGee, R. S., Homburger, J. R., Williams, H. E., Bergstrom, C. T. & Zhou, A. Y. Model-driven mitigation measures for reopening schools during the COVID-19 pandemic. PNAS 118, (2021).
  18. 18.
    Lasser, J. et al. Assessing the impact of SARS-CoV-2 prevention measures in Austrian schools using agent-based simulations and cluster tracing data. Nat Commun 13, 554 (2022).
    OpenUrl
  19. 19.↵
    Liu, Q.-H. et al. Model-based evaluation of alternative reactive class closure strategies against COVID-19. Nat Commun 13, 322 (2022).
  20. 20.↵
    Stephenson, T. et al. Long COVID - the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study. Research Square (2021) doi:10.21203/rs.3.rs-798316/v1.
    OpenUrlCrossRef
  21. 21.↵
    Lyngse, F. P. et al. SARS-CoV-2 Omicron VOC Transmission in Danish Households. medRxiv preprint 2021.12.27.21268278 (2021) doi:10.1101/2021.12.27.21268278.
    OpenUrlAbstract/FREE Full Text
Back to top
PreviousNext
Posted February 06, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022
Elisabetta Colosi, Giulia Bassignana, Alain Barrat, Bruno Lina, Philippe Vanhems, Julia Bielicki, Vittoria Colizza
medRxiv 2022.02.04.22270473; doi: https://doi.org/10.1101/2022.02.04.22270473
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022
Elisabetta Colosi, Giulia Bassignana, Alain Barrat, Bruno Lina, Philippe Vanhems, Julia Bielicki, Vittoria Colizza
medRxiv 2022.02.04.22270473; doi: https://doi.org/10.1101/2022.02.04.22270473

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (431)
  • Allergy and Immunology (757)
  • Anesthesia (221)
  • Cardiovascular Medicine (3298)
  • Dentistry and Oral Medicine (365)
  • Dermatology (280)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
  • Epidemiology (13385)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5158)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3276)
  • Health Policy (1143)
  • Health Systems and Quality Improvement (1193)
  • Hematology (432)
  • HIV/AIDS (1019)
  • Infectious Diseases (except HIV/AIDS) (14637)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (478)
  • Medical Ethics (127)
  • Nephrology (525)
  • Neurology (4930)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (886)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (728)
  • Orthopedics (282)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (544)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4218)
  • Public and Global Health (7512)
  • Radiology and Imaging (1708)
  • Rehabilitation Medicine and Physical Therapy (1016)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (498)
  • Sports Medicine (424)
  • Surgery (549)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)